Globus Medical Stock Gains Attention After Earnings Beat And Continued Growth
Published . Updated .
Globus Medical recently reported quarterly results that exceeded consensus forecasts for both adjusted earnings per share and revenue, continuing a pattern of outperformance over the past four quarters. Behind the headlines, the business has been expanding free cash flow
Directly affected
- GMED Globus Medical+0.6% 10d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Globus Medical belongs to, so it often moves with news about it.
- SYK Stryker+13.4% 30d
Stryker is a peer of Globus Medical in surgical and medical instruments and apparatus; rivals often move on the same news.
- MMM 3M+4.2% 30d
3M is a peer of Globus Medical in surgical and medical instruments and apparatus; rivals often move on the same news.
- BSX Boston Scientific-1.7% 30d
Boston Scientific is a peer of Globus Medical in surgical and medical instruments and apparatus; rivals often move on the same news.
- BDX Becton, Dickinson and+6.6% 30d
Becton, Dickinson and is a peer of Globus Medical in surgical and medical instruments and apparatus; rivals often move on the same news.
- MDLN Medline-12.6% 11d
Medline is a peer of Globus Medical in surgical and medical instruments and apparatus; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| GMED | +4.87% | +4.10% | base | after close | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| SYKNo price data for this ticker | — | — | — | — | — | — | — |
| MMMNo price data for this ticker | — | — | — | — | — | — | — |
| BSXNo price data for this ticker | — | — | — | — | — | — | — |
| BDXNo price data for this ticker | — | — | — | — | — | — | — |
| MDLNNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Globus Medical Stock Gains Attention After Earnings Beat And Continued Growth Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| GMED | three days earlier | +4.10% | final price |
| GMED | five days earlier | +4.87% | final price |
Congressional trades in the stocks in this story
- Rep. Gilbert Cisneros bought Globus Medical (GMED), worth $1,001 - $15,000 on 3 Sep 2026. That is 58 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Globus Medical (GMED), worth $15,001 - $50,000 on 19 Aug 2026. That is 73 days before publication. Filed 10 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Stryker (SYK) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 36 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Stryker (SYK) (held by a dependent child), worth $15,001 - $50,000 on 11 Sep 2026. That is 50 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Stryker (SYK) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 57 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 9 Sep 2026. That is 52 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (jointly held), worth $50,001 - $100,000 on 4 Sep 2026. That is 57 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Boston Scientific (BSX) (held by a dependent child), worth $1,001 - $15,000 on 3 Sep 2026. That is 58 days before publication. Filed 25 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Globus Medical Stock Gains Attention After Earnings Beat And Continued Growth” scores 12 out of 100. The score uses 1 sources.